Opyl is ready to scale up AI platform Opin after delivering full-year revenue growth

Opyl has successfully pivoted into the digital health business during the last financial year by launching its AI-based clinical trial recruitment platform, Opin.

“The most significant achievement and priority for the year was commercialising the first of its three artificial intelligence (AI) technology platforms, launching Opin to address the rapidly growing global clinical trials services market.” – as featured in a Stockhead article.

Read the full versionĀ here.